
### [MONDO:0000637](http://purl.obolibrary.org/obo/MONDO_0000637)
**Label:** musculoskeletal system cancer

**Subclasses:** [MONDO:0019438](http://purl.obolibrary.org/obo/MONDO_0019438) (AL amyloidosis), [MONDO:0011173](http://purl.obolibrary.org/obo/MONDO_0011173) (thrombocythemia 2), [MONDO:0013794](http://purl.obolibrary.org/obo/MONDO_0013794) (thrombocythemia 3), [MONDO:0009692](http://purl.obolibrary.org/obo/MONDO_0009692) (primary myelofibrosis), [MONDO:0009693](http://purl.obolibrary.org/obo/MONDO_0009693) (multiple myeloma), [MONDO:0019457](http://purl.obolibrary.org/obo/MONDO_0019457) (Therapy related acute myeloid leukemia and myelodysplastic syndrome), [MONDO:0019454](http://purl.obolibrary.org/obo/MONDO_0019454) (refractory anemia with excess blasts), [MONDO:0009993](http://purl.obolibrary.org/obo/MONDO_0009993) (embryonal rhabdomyosarcoma (disease)), [MONDO:0019111](http://purl.obolibrary.org/obo/MONDO_0019111) (familial thrombocytosis), [MONDO:0019452](http://purl.obolibrary.org/obo/MONDO_0019452) (chronic myeloproliferative disease, unclassifiable), [MONDO:0015691](http://purl.obolibrary.org/obo/MONDO_0015691) (hypereosinophilic syndrome), [MONDO:0005029](http://purl.obolibrary.org/obo/MONDO_0005029) (essential thrombocythemia), [MONDO:0020561](http://purl.obolibrary.org/obo/MONDO_0020561) (myxoid/round cell liposarcoma), [MONDO:0011996](http://purl.obolibrary.org/obo/MONDO_0011996) (chronic myelogenous leukemia), [MONDO:0007243](http://purl.obolibrary.org/obo/MONDO_0007243) (Burkitts lymphoma), [MONDO:0005164](http://purl.obolibrary.org/obo/MONDO_0005164) (fibrosarcoma (disease)), [MONDO:0005060](http://purl.obolibrary.org/obo/MONDO_0005060) (liposarcoma), [MONDO:0007063](http://purl.obolibrary.org/obo/MONDO_0007063) (long bone adamantinoma), [MONDO:0017834](http://purl.obolibrary.org/obo/MONDO_0017834) (secondary hypereosinophilic syndrome), [MONDO:0011118](http://purl.obolibrary.org/obo/MONDO_0011118) (bilineal acute myeloid leukemia), [MONDO:0017858](http://purl.obolibrary.org/obo/MONDO_0017858) (acute erythroid leukemia), [MONDO:0016824](http://purl.obolibrary.org/obo/MONDO_0016824) (myofibromatosis), [MONDO:0017386](http://purl.obolibrary.org/obo/MONDO_0017386) (pleomorphic rhabdomyosarcoma), [MONDO:0018874](http://purl.obolibrary.org/obo/MONDO_0018874) (acute myeloid leukemia), [MONDO:0002629](http://purl.obolibrary.org/obo/MONDO_0002629) (bone osteosarcoma), [MONDO:0018872](http://purl.obolibrary.org/obo/MONDO_0018872) (acute megakaryoblastic leukemia), [MONDO:0020078](http://purl.obolibrary.org/obo/MONDO_0020078) (acute myeloid leukemia with recurrent genetic anomaly), [MONDO:0020331](http://purl.obolibrary.org/obo/MONDO_0020331) (indolent systemic mastocytosis), [MONDO:0004948](http://purl.obolibrary.org/obo/MONDO_0004948) (chronic lymphocytic leukemia), [MONDO:0008554](http://purl.obolibrary.org/obo/MONDO_0008554) (thrombocythemia 1), [MONDO:0013280](http://purl.obolibrary.org/obo/MONDO_0013280) (myxoid liposarcoma), [MONDO:0020311](http://purl.obolibrary.org/obo/MONDO_0020311) (chronic myelomonocytic leukemia), [MONDO:0020312](http://purl.obolibrary.org/obo/MONDO_0020312) (atypical chronic myeloid leukemia), [MONDO:0020511](http://purl.obolibrary.org/obo/MONDO_0020511) (precursor b-cell acute lymphoblastic leukemia), [MONDO:0004967](http://purl.obolibrary.org/obo/MONDO_0004967) (acute lymphoblastic leukemia (disease)), [MONDO:0019460](http://purl.obolibrary.org/obo/MONDO_0019460) (acute leukemia of ambiguous lineage), [MONDO:0008977](http://purl.obolibrary.org/obo/MONDO_0008977) (chondrosarcoma (disease)), [MONDO:0008978](http://purl.obolibrary.org/obo/MONDO_0008978) (chordoma (disease)), [MONDO:0012817](http://purl.obolibrary.org/obo/MONDO_0012817) (Ewing sarcoma), [MONDO:0007896](http://purl.obolibrary.org/obo/MONDO_0007896) (acute monocytic leukemia), [MONDO:0005212](http://purl.obolibrary.org/obo/MONDO_0005212) (rhabdomyosarcoma (disease)), [MONDO:0005058](http://purl.obolibrary.org/obo/MONDO_0005058) (leiomyosarcoma), [MONDO:0020076](http://purl.obolibrary.org/obo/MONDO_0020076) (myeloproliferative neoplasm), [MONDO:0010434](http://purl.obolibrary.org/obo/MONDO_0010434) (synovial sarcoma (disease)), [MONDO:0015667](http://purl.obolibrary.org/obo/MONDO_0015667) (unclassified acute myeloid leukemia), [MONDO:0013667](http://purl.obolibrary.org/obo/MONDO_0013667) (myelodysplastic syndrome), 

**Corr. equiv. classes:** [Orphanet:86839](http://www.orpha.net/ORDO/Orphanet_86839), [OMIM:151380](http://purl.obolibrary.org/obo/OMIM_151380), [Orphanet:3273](http://www.orpha.net/ORDO/Orphanet_3273), [Orphanet:86830](http://www.orpha.net/ORDO/Orphanet_86830), [Orphanet:293199](http://www.orpha.net/ORDO/Orphanet_293199), [Orphanet:67038](http://www.orpha.net/ORDO/Orphanet_67038), [Orphanet:64720](http://www.orpha.net/ORDO/Orphanet_64720), [Orphanet:3318](http://www.orpha.net/ORDO/Orphanet_3318), [Orphanet:519](http://www.orpha.net/ORDO/Orphanet_519), [Orphanet:518](http://www.orpha.net/ORDO/Orphanet_518), [Orphanet:514](http://www.orpha.net/ORDO/Orphanet_514), [Orphanet:319](http://www.orpha.net/ORDO/Orphanet_319), [OMIM:612219](http://purl.obolibrary.org/obo/OMIM_612219), [OMIM:254500](http://purl.obolibrary.org/obo/OMIM_254500), [Orphanet:318](http://www.orpha.net/ORDO/Orphanet_318), [Orphanet:71493](http://www.orpha.net/ORDO/Orphanet_71493), [Orphanet:513](http://www.orpha.net/ORDO/Orphanet_513), [Orphanet:99860](http://www.orpha.net/ORDO/Orphanet_99860), [OMIM:268210](http://purl.obolibrary.org/obo/OMIM_268210), [Orphanet:69078](http://www.orpha.net/ORDO/Orphanet_69078), [OMIM:601626](http://purl.obolibrary.org/obo/OMIM_601626), [OMIM:300813](http://purl.obolibrary.org/obo/OMIM_300813), [OMIM:614286](http://purl.obolibrary.org/obo/OMIM_614286), [OMIM:113970](http://purl.obolibrary.org/obo/OMIM_113970), [OMIM:254450](http://purl.obolibrary.org/obo/OMIM_254450), [OMIM:614521](http://purl.obolibrary.org/obo/OMIM_614521), [Orphanet:98848](http://www.orpha.net/ORDO/Orphanet_98848), [Orphanet:168956](http://www.orpha.net/ORDO/Orphanet_168956), [Orphanet:668](http://www.orpha.net/ORDO/Orphanet_668), [OMIM:215400](http://purl.obolibrary.org/obo/OMIM_215400), [Orphanet:824](http://www.orpha.net/ORDO/Orphanet_824), [Orphanet:543](http://www.orpha.net/ORDO/Orphanet_543), [OMIM:259500](http://purl.obolibrary.org/obo/OMIM_259500), [Orphanet:314962](http://www.orpha.net/ORDO/Orphanet_314962), [OMIM:187950](http://purl.obolibrary.org/obo/OMIM_187950), [Orphanet:780](http://www.orpha.net/ORDO/Orphanet_780), [OMIM:601977](http://purl.obolibrary.org/obo/OMIM_601977), [Orphanet:85443](http://www.orpha.net/ORDO/Orphanet_85443), [Orphanet:86851](http://www.orpha.net/ORDO/Orphanet_86851), [Orphanet:98836](http://www.orpha.net/ORDO/Orphanet_98836), [OMIM:613488](http://purl.obolibrary.org/obo/OMIM_613488), [Orphanet:167714](http://www.orpha.net/ORDO/Orphanet_167714), [Orphanet:99967](http://www.orpha.net/ORDO/Orphanet_99967), [Orphanet:55880](http://www.orpha.net/ORDO/Orphanet_55880), [Orphanet:55881](http://www.orpha.net/ORDO/Orphanet_55881), [Orphanet:98274](http://www.orpha.net/ORDO/Orphanet_98274), [Orphanet:98277](http://www.orpha.net/ORDO/Orphanet_98277), [Orphanet:178](http://www.orpha.net/ORDO/Orphanet_178), [Orphanet:86846](http://www.orpha.net/ORDO/Orphanet_86846), [Orphanet:2591](http://www.orpha.net/ORDO/Orphanet_2591), [Orphanet:2030](http://www.orpha.net/ORDO/Orphanet_2030), [Orphanet:29073](http://www.orpha.net/ORDO/Orphanet_29073), [Orphanet:99757](http://www.orpha.net/ORDO/Orphanet_99757), [Orphanet:98823](http://www.orpha.net/ORDO/Orphanet_98823), [OMIM:215300](http://purl.obolibrary.org/obo/OMIM_215300), [Orphanet:98824](http://www.orpha.net/ORDO/Orphanet_98824), [OMIM:608232](http://purl.obolibrary.org/obo/OMIM_608232), [Orphanet:521](http://www.orpha.net/ORDO/Orphanet_521), [OMIM:102660](http://purl.obolibrary.org/obo/OMIM_102660), 

**Class expressions from DL-Learner:**

- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 34.17%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 32.96%
- Thing 32.94%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 32.94%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000003](http://purl.obolibrary.org/obo/HP_0000003) (Multicystic kidney dysplasia))) 30.26%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000011](http://purl.obolibrary.org/obo/HP_0000011) (Neurogenic bladder))) 30.23%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000016](http://purl.obolibrary.org/obo/HP_0000016) (Urinary retention))) 30.17%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 30.14%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000017](http://purl.obolibrary.org/obo/HP_0000017) (Nocturia))) 30.14%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000013](http://purl.obolibrary.org/obo/HP_0000013) (Hypoplasia of the uterus))) 30.14%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000012](http://purl.obolibrary.org/obo/HP_0000012) (Urinary urgency))) 30.14%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000004](http://purl.obolibrary.org/obo/HP_0000004) (null))) 30.14%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 27.12%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 22.35%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) 22.29%


